Mark Danta
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
Papers in
- Hepatology 54
- Hepatitis C virus research 38
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 7
- Epidemiology 12
- Hepatitis B Virus Studies 6
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Gail V. Matthews (8 shared papers)Geoffrey M Dusheiko (13 shared papers)Gregory J. Dore (16 shared papers)Behzad Hajarizadeh (9 shared papers)Janaki Amin (4 shared papers)Matthew G. Law (4 shared papers)Jason Grebely (4 shared papers)Jacob George (3 shared papers)
- Journals
- Hepatology (8 papers)Journal of Hepatology (6 papers)Alimentary Pharmacology & Therapeutics (4 papers)The Journal of Infectious Diseases (3 papers)AIDS (3 papers)
- Partner nations
- AustraliaUnited KingdomItaly
In The Last Decade
Mark Danta
87 papers receiving 3.2k citations
Mark Danta's Hit Papers
Peers
Comparison fields: 5 of 102
- Hepatology 2.1k
- Epidemiology 563
- Virology 71
- Infectious Diseases 139
- Microbiology 40
Countries citing papers authored by Mark Danta
This map shows the geographic impact of Mark Danta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Danta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Danta more than expected).
Fields of papers citing papers by Mark Danta
This network shows the impact of papers produced by Mark Danta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Danta. The network helps show where Mark Danta may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Danta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Hit paper breakdown → | 2020 | 414 |
| 2 | Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression Hit paper breakdown → | 2017 | 411 |
| 3 | Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2023 | 374 |
| 4 | 2007 | 355 | |
| 5 | 2009 | 267 | |
| 6 | 2010 | 199 | |
| 7 | 2012 | 95 | |
| 8 | 2020 | 95 | |
| 9 | 2008 | 91 | |
| 10 | 2022 | 75 | |
| 11 | 2012 | 53 | |
| 12 | 2011 | 50 | |
| 13 | 2011 | 46 | |
| 14 | 2007 | 35 | |
| 15 | 2016 | 33 | |
| 16 | 2018 | 33 | |
| 17 | 2014 | 30 | |
| 18 | 2021 | 30 | |
| 19 | 2008 | 29 | |
| 20 | 2017 | 28 |
About Mark Danta
Mark Danta is a scholar working on Hepatology, Epidemiology, Virology, Oncology and Gastroenterology, having authored 88 papers that have together received 3.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease and Transplantation (7 papers), Hepatitis B Virus Studies (6 papers), HIV Research and Treatment (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Pharmaceutical Economics and Policy (4 papers) and Colorectal Cancer Screening and Detection (3 papers). The work is most often cited by research in Hepatology (2.1k citations), Epidemiology (563 citations), Virology (71 citations), Infectious Diseases (139 citations) and Microbiology (40 citations). Mark Danta has collaborated with scholars based in Australia, United Kingdom and Italy. Frequent co-authors include Gail V. Matthews, Geoffrey M Dusheiko, Gregory J. Dore, Behzad Hajarizadeh, Janaki Amin, Matthew G. Law, Jason Grebely, Jacob George, Maria Prins and Reem Waziry. Their work appears in journals such as Hepatology, Journal of Hepatology, Alimentary Pharmacology & Therapeutics, The Journal of Infectious Diseases and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.